Theoretical study and application of 2-phenyl-1,3,4-thiadiazole derivatives with optical and inhibitory activity

Chun Zhang1, Yi-Tao Sun1, Li-Xin Gao1,2

  • 1School of Pharmaceutical Sciences, Jiangnan University, Wuxi, 214122, China. wwenlong2011@163.com.

Insights

Researchers developed a fluorescent molecule, PT10, to visualize and inhibit Src homology-2 domain-containing protein tyrosine phosphatase 1 (SHP1). This advancement aids in understanding SHP1

Area of Science:

  • Biochemistry
  • Chemical Biology
  • Molecular Imaging

Background:

  • Src homology-2 domain-containing protein tyrosine phosphatase 1 (SHP1) is a key regulator in oncogenic signaling pathways.
  • Targeting SHP1 is crucial for developing novel cancer therapies.
  • Efficient methods for SHP1 activity tracing and inhibition are needed.

Purpose of the Study:

  • To design and synthesize novel 2-phenyl-1,3,4-thiadiazole derivatives as SHP1 inhibitors.
  • To investigate the photophysical properties and inhibitory activities of these compounds.
  • To develop a fluorescent probe for SHP1 activity visualization and inhibition.

Main Methods:

  • Synthesis of ten 2-phenyl-1,3,4-thiadiazole derivatives (PT1-PT10).
  • Theoretical simulations and experimental studies of photophysical properties and SHP1 inhibitory activity.
  • In vitro assays including fluorescence spectroscopy and cytotoxicity tests in HeLa cells.

Main Results:

  • Compound PT10 demonstrated superior fluorescence quantum yield due to reduced excited-state relaxation.
  • PT10 selectively responded to SHP1 activity with low cytotoxicity.
  • Calculated two-photon absorption properties suggest potential for advanced cell imaging.

Conclusions:

  • A novel fluorescent inhibitor, PT10, was developed for SHP1.
  • PT10 integrates visualization and inhibitory functions at the molecular level.
  • This offers a promising tool for SHP1-related disease research and diagnostics.